Controlled release dosage form with enhanced pharmacokinetics

The present invention provides a simple and improved dosage form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically respons...

Full description

Saved in:
Bibliographic Details
Main Authors Fischbein, Gustavo A, Meyer, Glenn A, Franco, Cristian R, Wright, Claude E
Format Patent
LanguageEnglish
Published 08.08.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a simple and improved dosage form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
Bibliography:Application Number: US202117222382